Executive Summary: Introduction: Following recent legislation and proposed regulations that look to reduce Medicare or other state-funded spending to that of other similarly situated countries, these reforms may overlook the key differences of the drivers of each nation’s individual health care marketplace. While – international comparisons can sometimes be helpful, comparing the price, reimbursement, and … Continue reading
Author Archives: Anna Grace Shepherd
Inhaler Pricing: A Lack of Market Competition
Executive Summary: Introduction: On January 8th, 2024 the Senate Committee on Health, Education, Labor, and Pensions (HELP) sent letters to the CEOs of the four largest manufacturers of inhalers sold in the United States (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK), and Teva) launching an investigation into the high price of inhalers used for Asthma and Chronic … Continue reading
Housing as Healthcare: Medicaid’s New Program Sparks Debate
Executive Summary: Introduction: On November 16th, 2023, The Biden Administration released a press statement in collaboration with the U.S. Department of Housing and Urban Development announcing the Medicaid and Children’s Health Insurance Program (CHIP) Health-Related Social Needs (HRSN) Framework, a framework that sets up states to use appropriate interventions to support housing efforts for certain Medicaid … Continue reading
The MOM Model: New Strides and Shortcomings in the Fight Against Maternal Opioid Misuse
Executive Summary: Introduction: In May of 2023, the Center for Medicare and Medicaid Innovation Center published its second-year evaluation report, noting low enrollment and barriers in providing equitable care, pointing to a challenging first year of implementation in the MOM (Maternal Opioid Misuse) Model. The Center for Medicare and Medicaid Innovation Center created the MOM … Continue reading